BLT 0.00% 2.6¢ benitec biopharma limited

renaissance capital, page-34

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    Read the Use of Proceeds. It clearly states that $7.7M will be spent on the current TT-034 trial. So, even with our current bank balance, we don't have enough capital to complete the trial. No wonder we have to IPO now.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.